Zobrazeno 1 - 10
of 137
pro vyhledávání: '"G. Bottero"'
Autor:
F. Montefiore, C. Lozzi, G. Bottero, M. Rossi, V. Fusco, S. Treffiletti, S. Annoscia, D. Tiranti, G. Pozzi, C. Boccafoschi
Publikováno v:
Urologia Journal. 60:329-333
Twenty-two patients with operable bladder carcinoma (stage T3, T2, and T1m “high risk”), all G3–G4 except 2, have been recommended for 3 courses of methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC). Eight pathological Complete Respon
Autor:
G. Margarino, S. Vitriolo, M. Cavallari, Leonardo Santi, Renzo Corvò, Giovanni Cordone, Fulvio Brema, Marco Merlano, Marco Benasso, F. Scasso, R. Rosso, Marina Guenzi, E. Accomando, A. Siragusa, G. Luzi, G. Biondi, Alida Santelli, G. Bottero, Mario Roberto Sertoli, Marco Scala, G. Comella, G. Garaventa
Publikováno v:
Cancer. 67:915-921
Between 1983 and 1986, the National Institute for Cancer Research in Genoa and affiliated institutions conducted a randomized study to compare two different ways of combining chemotherapy (CT) and radiation therapy (RT). One hundred sixteen patients
Publikováno v:
European Neuropsychopharmacology. 21:S565-S566
Autor:
C, Coletta, R, Ricci, V, Ceci, F, Seccareccia, F, Rulli, V, Mazzuca, R L, Putini, A, Salustri, G, Bottero, M, Pasquale
Publikováno v:
Giornale italiano di cardiologia. 29(2)
The RIMA (Rimodellamento Infarto Miocardico Acuto) study was designed to assess the relative effects of angiotensin-converting enzyme (ACE) inhibition by captopril, beta-blocker therapy by metoprolol, and their combination in patients with a first ac
Publikováno v:
Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 46(2)
The optimal treatment of prostate cancer in clinical stage C is controversial. On the one hand a disease still confined by definition, as stage C is, should require a curative therapy such as surgery or radiotheratherapy. On the other hand the known
Autor:
Roberta Libener, M. Botta, G. Bottero, E. Piccolini, R.G. Betta, Paola Franzone, F. Florio, Annalisa Roveta, D. Degiovanni, Federica Grosso
Publikováno v:
European Journal of Cancer. 47:S637
Autor:
N. F. Trincheri, Dario Mirabelli, Federica Grosso, Roberta Libener, M. Pavesi, M. Botta, Annalisa Roveta, G. Bottero, L. Giaretto, E. Piccolini, Pier Giacomo Betta, T. Bensi
Publikováno v:
Journal of Clinical Oncology. 29:e21033-e21033
e21033 Background: The median overall survival (OS) of MPM patients (pts) is 10-month. However a small number of pts survive beyond 24 months (mos) and are considered LS. Here we report on the clin...
Publikováno v:
Surgical oncology. 2(1)
This study was undertaken to relate the expression of the proliferating cell nuclear antigen (PCNA), a proliferation marker of putative prognostic significance, to some more established prognostic factors in a series of 60 consecutive breast cancer s
Autor:
T. Bensi, Pier Giacomo Betta, E. Arnolfo, N. F. Trincheri, G. Bottero, Federica Grosso, Sara Orecchia, M. Botta, E. Piccolini, Roberta Libener
Publikováno v:
Journal of Clinical Oncology. 28:e21021-e21021
e21021 Background: Malignant mesothelioma (MM) is an aggressive neoplasm of the serosal cavities, resistant to conventional treatment, for which new therapeutic targets are being actively sought. A...
Publikováno v:
Minerva chirurgica. 47(12)
A prospective study of surgical infections in our Department of Surgery in the years 1986-1989 is reported. 2719 patients entered the study: they represent the total number of patients operated in the above said period (628 urgent and 2091 elective o